Related Experiment Video
Updated: Sep 18, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic Cardiomyopathy and Pregnancy
Amha Weldehana1, Beeletsega Yeneneh2, Samrawit Zewde3
1From the Department of Cardiology, Westchester Medical Center, Valhalla, NY.
Hypertrophic cardiomyopathy (HCM) in pregnancy is increasingly common. While often well-tolerated, this review examines diagnosis, risks, and management for expectant mothers with HCM.
Area of Science:
- Cardiology
- Genetics
- Obstetrics
Background:
- Hypertrophic cardiomyopathy (HCM) is an inherited condition affecting the heart muscle.
- Increased screening leads to more women of reproductive age with HCM becoming pregnant.
- Limited evidence exists on managing HCM during pregnancy.
Purpose of the Study:
- To review the epidemiology of HCM in pregnancy.
- To discuss clinical presentation and diagnostic challenges.
- To outline management strategies for pregnant patients with HCM.
Main Methods:
- Literature review of observational studies.
- Analysis of clinical evidence on HCM and pregnancy.
- Synthesis of data on diagnosis, risk stratification, and management.
Main Results:
- HCM is generally well-tolerated during pregnancy for many women.
- Normal pregnancy and delivery outcomes are frequently observed.
- Potential complications necessitate pre-pregnancy intervention considerations.
Conclusions:
- Pregnancy in women with HCM requires careful consideration of potential risks.
- Early diagnosis and risk stratification are crucial.
- Management strategies should be individualized, with potential need for advanced interventions.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Mitral Valve Prolapse III: Nursing Management

